08:15 AM EST, 02/18/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) on Tuesday said it has appointed Alex Rothwell as chief financial officer, effective immediately.

Rothwell, who previously served as the company's CFO takes over from Bruce Cousins who is retiring, but will remain in a consultant role during the transition.

"I believe [Rothwell's] public markets and deal expertise, and his deep familiarity with Eupraxia and its shareholders, will make [him] a key contributor to our senior leadership team as Eupraxia advances its programs in EP-104GI and EP-104AR," said Chief Executive James Helliwell.